What was the overall market valuation of the US esophageal dysphagia market in 2024?

The overall market valuation was $424.2 Million in 2024. Read More

What is the projected market valuation for the US esophageal dysphagia market by 2035?

The projected market valuation for 2035 is $800.0 Million. Read More

What is the expected CAGR for the US esophageal dysphagia market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.94%. Read More

Which companies are considered key players in the US esophageal dysphagia market?

Key players include Medtronic, Boston Scientific, Johnson & Johnson, Abbott Laboratories, and Cook Medical. Read More

What segment had the highest valuation in the diagnosis category for the US esophageal dysphagia market?

Endoscopy had the highest valuation in the diagnosis category, ranging from $100.0 Million to $200.0 Million. Read More

What is the valuation range for esophageal dilation in the treatment segment?

The valuation range for esophageal dilation in the treatment segment is $80.0 Million to $150.0 Million. Read More

Which product segment is projected to have the highest valuation in the US esophageal dysphagia market?

The drugs segment is projected to have a valuation range of $80.0 Million to $160.0 Million. Read More

What is the valuation range for hospitals and clinics as end-users in the US esophageal dysphagia market?

The valuation range for hospitals and clinics as end-users is $169.68 Million to $320.0 Million. Read More

How does the valuation of imaging scans compare to that of manometry in the diagnosis segment?

Imaging scans range from $70.0 Million to $140.0 Million, whereas manometry ranges from $40.0 Million to $80.0 Million. Read More

What treatment options are included in the US esophageal dysphagia market?

Treatment options include esophageal dilation, surgery, stent placement, and medications, among others. Read More

US Esophageal Dysphagia Market

ID: MRFR/MED/18384-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Esophageal Dysphagia Market Research Report By Diagnosis (Dynamic Swallowing Study, X-ray, Endoscope, Manometry, Imaging scans, MRI scan, CT scan), By Treatment (Esophageal Dilation, Surgery, Stent placement, Laparoscopic Heller Myotomy, Medications, Lifestyle Changes), By Product (Feeding Tube, Nasogastric Tube, Percutaneous Endoscopic Gastrostomy, Nutritional Solutions, Thickeners, Beverages, Purees, Drugs, Proton Pump Inhibitors, Other) and By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Centers, Others) - Growth & Industry Forecast 2025 To 2035

US Esophageal Dysphagia Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Diagnosis (USD Million)
  1. 4.1.1 Dynamic Swallowing Study
  2. 4.1.2 X-ray
  3. 4.1.3 Endoscopy
  4. 4.1.4 Manometry
  5. 4.1.5 Imaging scans
  6. 4.1.6 MRI scan
  7. 4.1.7 CT scan
2. 4.2 Life Sciences, BY Treatment (USD Million)
  1. 4.2.1 Esophageal Dilation
  2. 4.2.2 Surgery
  3. 4.2.3 Stent placement
  4. 4.2.4 Laparoscopic Heller Myotomy
  5. 4.2.5 Medications
  6. 4.2.6 Lifestyle Changes
3. 4.3 Life Sciences, BY Product (USD Million)
  1. 4.3.1 Feeding Tubes
  2. 4.3.2 Nasogastric Tubes
  3. 4.3.3 Percutaneous Endoscopic Gastrostomy
  4. 4.3.4 Nutritional Solutions
  5. 4.3.5 Thickeners
  6. 4.3.6 Beverages
  7. 4.3.7 Purees
  8. 4.3.8 Drugs
  9. 4.3.9 Proton Pump Inhibitors
  10. 4.3.10 Others
4. 4.4 Life Sciences, BY End-User (USD Million)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Diagnostic Centers
  4. 4.4.4 Research Centers
  5. 4.4.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Abbott Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cook Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Olympus Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Conmed Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 B. Braun Melsungen AG (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS
3. 6.3 US MARKET ANALYSIS BY TREATMENT
4. 6.4 US MARKET ANALYSIS BY PRODUCT
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY DIAGNOSIS, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TREATMENT, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TREATMENT, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DIAGNOSIS, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY PRODUCT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Diagnosis (USD Million, 2025-2035)

Dynamic Swallowing Study
X-ray
Endoscopy
Manometry
Imaging scans
MRI scan
CT scan

Life Sciences By Treatment (USD Million, 2025-2035)

Esophageal Dilation
Surgery
Stent placement
Laparoscopic Heller Myotomy
Medications
Lifestyle Changes

Life Sciences By Product (USD Million, 2025-2035)

Feeding Tubes
Nasogastric Tubes
Percutaneous Endoscopic Gastrostomy
Nutritional Solutions
Thickeners
Beverages
Purees
Drugs
Proton Pump Inhibitors
Others

Life Sciences By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Research Centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”